🇺🇸 FDA
Patent

US 7528138

Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7528138 (Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/18, A61P11/00